Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$93.74 USD

93.74
2,346,783

-0.36 (-0.38%)

Updated Jul 15, 2024 04:00 PM ET

After-Market: $93.76 +0.02 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Indrajit Bandyopadhyay headshot

US States Get $26B Settlement Deal in Opioid Abuse Litigation

Attorney generals of several states reach settlement deal with J&J (JNJ) and three drug distributors - MCK, CAH and ABC - related to thousands of opioid abuse litigations. Non-participating states may join the deal soon.

Cardinal Health (CAH) Introduces 2 New Digital Solutions

Cardinal Health (CAH) launches NavixRx Compliance Packaging and E-Commerce Storefront to allow independent pharmacists to expand services and support medication adherence.

Trina Mukherjee headshot

3 Stocks to Tap the Promising Dental Supplies Industry

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, segmental weakness is a woe.

Cardinal Health's (CAH) Arm Receives FDA Nod for LYMPHOSEEK

Cardinal Health's (CAH) Nuclear & Precision Health Solutions receive FDA approval for LYMPHOSEEK injection.

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, segmental weakness is a woe.

PerkinElmer (PKI) Boosts Cell Biology Portfolio With Buyout

PerkinElmer (PKI) enters into an agreement to acquire Nexcelom that will enable the former to boost its efforts when it comes to solutions for drug discovery.

Cardinal Health (CAH) Q3 Earnings & Revenues Miss Estimates

Cardinal Health's (CAH) fiscal third-quarter results reflect weakness in Pharmaceutical segment.

Cardinal Health (CAH) Q3 Earnings and Revenues Lag Estimates

Cardinal (CAH) delivered earnings and revenue surprises of -3.16% and -1.78%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Cardinal Health (CAH) to Post Q3 Earnings: What's in Store?

Cardinal Health's (CAH) fiscal third-quarter results are likely to reflect solid performance in Pharmaceutical segment.

Cardinal Health (CAH), HHS Partner to Offer Pandemic Support

The contract should help Cardinal Health (CAH) provide critical pandemic support in partnership with the U.S. government.

Why Cardinal (CAH) Could Beat Earnings Estimates Again

Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Here's Why You Should Hold on to Cardinal Health (CAH) Stock

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio.

Cardinal Health (CAH) Unveils Navista TS to Boost Patient Care

Cardinal Health (CAH) Specialty Solutions' newly launched Navista TS will help community oncologists to improve patient care and become successful in value-based care while reducing costs.

Ecolab (ECL) Unveils Its Enhanced Smart Water Navigator

Ecolab's (ECL) smart tool is expected to bridge the widening gap between freshwater supply and demand via efficient water management.

AmerisourceBergen (ABC) Hits New 52-Week High: What's Driving It?

AmerisourceBergen (ABC) is optimistic about maintaining a robust segmental performance amid the pandemic-led business disruptions.

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab

Cardinal Health (CAH) Hits New 52-week High: What's Driving It?

Cardinal Health (CAH) is witnessing an uptrend in its stock price, prompted by robust performance in both Pharmaceutical and Medical segments during the fiscal second quarter.

Trina Mukherjee headshot

MedTech to Gain From Economic Stimulus Bill: 3 Stocks to Buy

Grab these three top stocks - ABT, HOLX and BIO - that continue to show tremendous promise and stand to benefit from the historic stimulus package.

Cardinal Health (CAH) Inks Deal to Divest Cordis Business

Cardinal Health (CAH) divests its Cordis business to focus on strategic growth areas.

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio.

Trina Mukherjee headshot

3 Stocks to Capitalize on Promising Dental Supplies Industry

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Cardinal Health (CAH) Q2 Earnings & Revenues Top Estimates

Cardinal Health's (CAH) fiscal second-quarter results reflect strong segmental performance.